VetWatch reports lower vaccine and parasite-control spending. Vetsource’s US sample averaged fewer new puppy and kitten patients per practice in 2025. This edition also covers approval of Convenia RTU for Dogs, a survey on staff stress and an Accuplex test comparison. The focus is local demand, staff time and full costs before changing orders, services or tests.
Synchrony, Antech and Instinct announced links for clinic payments, test results and imaging reports. Digitail’s survey found that some users still move data by hand. Cronus announced US distribution of Florfinasone Otic for certain outer ear infections in dogs. This edition focuses on full task times, software limits and buying costs before clinics change systems or orders.
IDEXX bought CoVetAI and plans clinic software links. Loyal reports that the US Food and Drug Administration accepted an LOY-003 effectiveness section; approval remains undecided. Nationwide expanded VetHelpline visits with possible prescriptions in 11 states and the District of Columbia. Vetology says it rebuilt 94 X-ray screening models. The Edition focuses on note handoffs, fill requests and X-ray review time.
Comments on US animal vaccine rules close October 13. Elanco reports more Credelio Quattro clinics, while Vetoquinol reports higher US sales across all species. CUBEX launched a cabinet to track medicine use. Cat owners spent more on food on average in 2025. This edition's focus is repeat sales, staff time and stock costs before changing orders or forecasts.
Chewy added debt as it spent on acquisitions, new sites and share buybacks. Petco’s product sales fell as services and other revenue grew. This edition also covers Fi’s recall of two dog supplement lots, screwworm prevention uses and updated kidney care guidance for cats. The focus is orders, clinic earnings and the costs of stock, staff and growth.
US FDA proposed an animal-drug compounding policy for registered facilities, while Vetsource reported deeper declines in visits, product revenue and preventive dispensing. This PULSE edition also covers canine diabetes guidance, staff-reported care-decline thresholds, a bedinvetmab X-ray pattern in selected safety reports and Vet Intel’s acquisition of Antelligence.
Zoetis’ US companion animal revenue fell; Elanco’s US Pet Health revenue grew. Tractor Supply added more than 200 pet products; Medi-Span launched veterinary drug checks; Trupanion’s subscription pets grew as total enrollment fell. This edition covers MWI’s settlement over drug-order allegations and a federal complaint seeking to halt Darwin’s pet food production.
Two US practice data samples showed more revenue while visit, client, invoice or patient counts fell. US pet insurers wrote more direct premiums in 2025; Merck and Hill’s global sales rose in the second quarter. American Regent recalled 2 Adequan Canine lots after it found glass fibers.
Tractor Supply plans to close about 75 Petsense stores, and Central Garden & Pet agreed to buy about 80% of TRIXIE. Mexico’s screwworm certificate rule starts August 3, and Vermont approved entry controls; Royal Canin expanded Amazon access. This edition also covers customer stock cuts, a delayed launch shipment and 3 recalled cyclophosphamide lots.
CVS pages conflicted on pet-prescription availability, and Texas added three screwworm zones and revised Zone 14.A. This edition also covers FDA animal-drug manufacturing incentives, Four Corners’ purchase of 102 Mission-operated properties, and Virbac companion animal growth alongside lower total North American revenue.
Revenue rose while patient counts and preventive purchases fell. Zoetis agreed to buy VitalRADS, and Bond Vet and Small Door completed their merger. This edition also covers Royal Canin’s fresh therapeutic dog diets, the PetMeds–Rural King online pharmacy, and an FDA proposal for shared registration across linked drug-making sites.
Revenue stayed positive this week, but data showed weaker patients, invoices, clients, and purchases. Heart + Paw care plans make clinics check service completion, technician time, and renewals. MSD allergy switching data show pressure on refill follow-up and cost explanations. AVMA’s FIP and poison-call updates add prescription-handoff, compounding, exposure question, and medicine-storage checks. Early watch items include Prime Day price checks and New World screwworm intake steps.
